BPG is committed to discovery and dissemination of knowledge
Articles in Press
12/19/2025 11:22:03 AM | Browse: 23 | Download: 0
Publication Name World Journal of Radiology
Manuscript ID 116084
Country China
Category Gastroenterology & Hepatology
Manuscript Type Letter to the Editor
Article Title Radiotherapy and bevacizumab in gastrointestinal cancers: Balancing efficacy against the risk of intestinal perforation
Manuscript Source Invited Manuscript
All Author List Yan Xu, Xiao-Bing Huang and Yong-Gang He
Funding Agency and Grant Number
Corresponding Author Yong-Gang He, Associate Chief Physician, Department of Hepatobiliary, The Second Affiliated Hospital of Army Medical University, No. 83 Xinqiaozheng Street, Chongqing 400037, China. xqyyhyg@tmmu.edu.cn
Key Words Radiotherapy; Bevacizumab; Gastrointestinal cancers; Intestinal perforation; Combination therapy; Toxicity management
Core Tip The combination of radiotherapy and bevacizumab in gastrointestinal cancers offers enhanced efficacy but requires careful management due to an increased risk of intestinal perforation. Strategic patient selection and advanced radiotherapy techniques are essential to balance benefits and risks.
Citation Xu Y, Huang XB, He YG. Radiotherapy and bevacizumab in gastrointestinal cancers: Balancing efficacy against the risk of intestinal perforation. World J Radiol 2025; In press
Received
2025-11-02 11:20
Peer-Review Started
2025-11-02 11:20
First Decision by Editorial Office Director
2025-11-05 07:47
Return for Revision
2025-11-05 12:16
Revised
2025-11-15 15:27
Publication Fee Transferred
Second Decision by Editor
2025-12-19 02:37
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director
2025-12-19 11:22
Articles in Press
2025-12-19 11:22
Edit the Manuscript by Language Editor
2025-12-22 03:33
Typeset the Manuscript
ISSN 1949-8470 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com